A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease

RecruitingOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

October 25, 2019

Primary Completion Date

May 1, 2025

Study Completion Date

August 1, 2026

Conditions
Sickle Cell Disease
Interventions
DEVICE

FDNIRS-DCS

FDNIRS-DCS measurements will be performed at the same time as all MRI scans. Participants in Group 4 will have additional measurements before, during, and after the their scheduled transfusion.

DEVICE

MRI

Participants in Groups 1-3 will receive a single, hour-long MRI. Participants in Group 4 will receive two, one hour long MRI scans: one within a week prior to their transfusion and one within a week after their transfusion.

Trial Locations (1)

02115

RECRUITING

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Boston Children's Hospital

OTHER